4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-077495
Chief Executive Officer sold 15,659 shares at $7.22 ($113,058)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2024-06-25 | Sale 10b5-1 | −15,659 | $7.22 | $113,058 | 564,543 | D |
| Open-market sales · 15,659 sh · avg $7.22 · $113,058 | |||||||
Loading xslF345X05/ownership.xml…